Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Cardiovascular Therapeutic Drugs: Technologies and Global Markets | Jul 2010 | £3,065 | 100% |
| Therapeutic Drugs for Central Nervous System (CNS) Disorders Technologies and Global Markets |
Sep 2010 | £3,065 | 99% |
| Stroke Therapy Area Pipeline Report | Mar 2011 | £945 | 87% |
| Neuroprotection (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 84% |
| Epidemiology: Depression | Dec 2010 | £3,605 | 84% |
| The Cardiovascular Market Outlook to 2016 Healthcare |
Jun 2011 | £2,425 | 84% |
| Brain Hemorrhage Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Nov 2011 | £2,215 | 83% |
| Epidemiology: Major Orthopedic Surgery On the rise as the global elderly population continues to grow |
May 2011 | £3,605 | 81% |
| Stakeholder Insight: Atrial Fibrillation Limited efficacy and poor safety lead to bleak outlook |
Oct 2006 | £8,365 | 81% |
| Acute Ischemic Stroke (AIS) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Sep 2011 | £2,215 | 80% |
| Boston Scientific Sells its Neurovascular Business to Stryker A Move to Invest in Future Growth Opportunities - Deal Analysis From GlobalData |
Nov 2010 | £315 | 74% |
| Cardiovascular Medicine Diagnostics, Drugs and Devices |
Jan 2007 | £2,760 | 72% |
| Cardiovascular Medicine: Diagnostics, Drugs and Devices | Jan 2007 | £2,760 | 71% |
| Stakeholder Insight: Major Depressive Disorder Gaining traction among physicians is crucial in an SSRI-dominated market |
Dec 2010 | £9,615 | 70% |
| Biomarkers (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 69% |
| Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 | Jun 2011 | £2,215 | 68% |
| Cardiac Implants Cardiac Implants |
Sep 2008 | £2,845 | 66% |
| Peripheral Vascular Devices Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 |
Feb 2011 | £1,500 | 65% |
| New Anticoagulant Therapies A Market Briefing |
Oct 2004 | £565 | 64% |
| The Pharmaceutical Market: India | Oct 2011 | £595 | 64% |
| Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices | Sep 2007 | £1,820 | 63% |
| Cardiac Pacemakers Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 |
Feb 2011 | £1,155 | 63% |
| Cardiac Catheters Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 |
Feb 2011 | £1,215 | 63% |
| Global Peripheral Vascular Devices Market Growth Analysis, 2009-2015 |
Feb 2011 | £2,480 | 63% |
| Acute Coronary Syndrome | Apr 2010 | £2,180 | 63% |
| Electrocardiography (ECG) Devices Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 |
Feb 2011 | £1,330 | 63% |
| Global Cardiac Pacemakers Market Growth Analysis, 2009-2015 |
Feb 2011 | £2,045 | 63% |
| Diagnostic Electrophysiology Catheters Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 |
Feb 2011 | £1,100 | 63% |
| Global Cardiac Catheters Market Growth Analysis, 2009-2015 |
Feb 2011 | £2,070 | 63% |
| Cardiac Defibrillators Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 |
Feb 2011 | £1,330 | 62% |
